Total Funding
84
48
Total FundingVenture - Series Unknown raised
Growth Score 84 in past quarter
-7 pts
Heat Score 48 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
763431
ViaCell is a biotechnology company focused on the area of women’s health.
Acquired by 

PerkinElmer
Cynthia Fisher: Co-founder- Morey Kraus: Co-Founder and CTO
About the Company
ViaCell is a biotechnology company focused on the area of women’s health. The company develops ViaCord, which enables families preserve their baby’s umbilical cord blood at the time of birth for possible future medical use; and ViaCyte, to broaden reproductive choices for women through the cryopreservation of human unfertilized eggs.
ViaCell is
based in Boston, Massachusetts.
Women Founded
